What can healthcare systems learn from looking at tensions in innovation processes? A systematic literature review.

Healthcare system Innovation Process System innovation Systematic literature review Tensions

Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
28 Oct 2022
Historique:
received: 30 03 2022
accepted: 30 09 2022
entrez: 29 10 2022
pubmed: 30 10 2022
medline: 2 11 2022
Statut: epublish

Résumé

Until now, scholarship on innovation processes in healthcare systems lack an in-depth appreciation of tensions. Tensions often revolve around barriers and result from individual assessments and prioritizations that guide actions to eventually overcome these barriers. In order to develop a more differentiated understanding of tensions' role in healthcare innovation processes, this paper aims to shed light on the multifaceted ways in which tensions emerge, are being dealt with, and how they hinder or, at times, facilitate innovation processes. A systematic review of published and grey literature was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guideline. The review involved searching three databases for original research articles and manually searching citations. Twenty-nine original full texts were identified, evaluated, and coded. These include papers on innovation in healthcare systems that investigated innovation-related organizational tensions. The findings were synthesized into different types of tensions in healthcare system innovation and the descriptions of the conflicting elements. We also analyzed the investigated innovations by type, process stages, and across different countries and healthcare systems. A total of forty-two tensions were identified and grouped into nine categories. Organizing tensions were predominant, followed by learning/belonging, performing, and performing/organizing tensions. Tensions most frequently occurred in the implementation phase and in the form of a dilemma. Included studies were conducted mainly in government-funded healthcare systems. Our data suggest that innovation processes in healthcare systems are impaired by conflicts between contradictory elements, working cultures, and convictions and the organizational and regulatory context. Since the majority of the tensions we collected in our study can be addressed, future policy-making and research should take advantage of this fact and develop strategies that significantly influence the successful management of tensions and thus improve the implementation of innovations.

Sections du résumé

BACKGROUND BACKGROUND
Until now, scholarship on innovation processes in healthcare systems lack an in-depth appreciation of tensions. Tensions often revolve around barriers and result from individual assessments and prioritizations that guide actions to eventually overcome these barriers. In order to develop a more differentiated understanding of tensions' role in healthcare innovation processes, this paper aims to shed light on the multifaceted ways in which tensions emerge, are being dealt with, and how they hinder or, at times, facilitate innovation processes.
METHODS METHODS
A systematic review of published and grey literature was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guideline. The review involved searching three databases for original research articles and manually searching citations. Twenty-nine original full texts were identified, evaluated, and coded. These include papers on innovation in healthcare systems that investigated innovation-related organizational tensions. The findings were synthesized into different types of tensions in healthcare system innovation and the descriptions of the conflicting elements. We also analyzed the investigated innovations by type, process stages, and across different countries and healthcare systems.
RESULTS RESULTS
A total of forty-two tensions were identified and grouped into nine categories. Organizing tensions were predominant, followed by learning/belonging, performing, and performing/organizing tensions. Tensions most frequently occurred in the implementation phase and in the form of a dilemma. Included studies were conducted mainly in government-funded healthcare systems.
CONCLUSION CONCLUSIONS
Our data suggest that innovation processes in healthcare systems are impaired by conflicts between contradictory elements, working cultures, and convictions and the organizational and regulatory context. Since the majority of the tensions we collected in our study can be addressed, future policy-making and research should take advantage of this fact and develop strategies that significantly influence the successful management of tensions and thus improve the implementation of innovations.

Identifiants

pubmed: 36307839
doi: 10.1186/s12913-022-08626-7
pii: 10.1186/s12913-022-08626-7
pmc: PMC9617372
doi:

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1299

Informations de copyright

© 2022. The Author(s).

Références

Health Policy Plan. 2007 Jan;22(1):28-39
pubmed: 17237492
BMC Public Health. 2016 May 17;16:412
pubmed: 27185039
Health Soc Care Community. 2022 May;30(3):856-868
pubmed: 34558143
Milbank Q. 2014 Dec;92(4):725-53
pubmed: 25492602
Implement Sci. 2017 Dec 01;12(1):143
pubmed: 29191230
Pediatrics. 2011 Apr;127(4):e1042-7
pubmed: 21422090
J Telemed Telecare. 2020 Jan-Feb;26(1-2):79-91
pubmed: 30193566
J Interprof Care. 2020 May-Jun;34(3):332-342
pubmed: 31329469
Implement Sci. 2006 Aug 24;1:18
pubmed: 16930484
Qual Health Res. 2010 Jul;20(7):922-30
pubmed: 19959823
Int J Integr Care. 2018 Jan 16;18(1):5
pubmed: 29632455
Implement Sci. 2018 Jul 4;13(1):91
pubmed: 29973225
Health Policy. 2018 Oct;122(10):1063-1069
pubmed: 30075865
Implement Sci. 2018 Jun 5;13(1):76
pubmed: 29866141
Acad Med. 2020 May;95(5):682-685
pubmed: 31833857
BMC Health Serv Res. 2011 Dec 16;11:342
pubmed: 22176739
J Adv Nurs. 2005 Aug;51(4):396-405
pubmed: 16086808
Pediatrics. 2004 Jan;113(1 Pt 2):217-27
pubmed: 14702504
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
J Health Organ Manag. 2018 Mar 19;32(1):39-55
pubmed: 29508667
Implement Sci. 2015 Oct 06;10:140
pubmed: 26444275
Health Res Policy Syst. 2010 May 13;8:12
pubmed: 20465809
Implement Sci. 2014 Oct 21;9:129
pubmed: 25331942
Jt Comm J Qual Improv. 1995 Jul;21(7):324-8
pubmed: 7581733
Health Res Policy Syst. 2018 Aug 3;16(1):74
pubmed: 30075735
J Health Organ Manag. 2020 Dec 8;ahead-of-print(ahead-of-print):
pubmed: 33277889
BMC Health Serv Res. 2017 Sep 19;17(1):670
pubmed: 28927451
JAMA. 2003 Apr 16;289(15):1969-75
pubmed: 12697800
Implement Sci. 2013 Aug 26;8:97
pubmed: 23972055
BMC Health Serv Res. 2018 Aug 3;18(1):600
pubmed: 30075772
Implement Sci. 2018 Mar 1;13(1):38
pubmed: 29490671
Implement Sci. 2010 Mar 13;5:21
pubmed: 20226066
Int J Electron Healthc. 2008;4(3-4):221-35
pubmed: 19174359
Ann Fam Med. 2014 Nov-Dec;12(6):573-6
pubmed: 25384822
BMC Health Serv Res. 2017 Jul 12;17(1):481
pubmed: 28701232
Harv Bus Rev. 2006 May;84(5):58-66, 156
pubmed: 16649698
BMC Health Serv Res. 2008 Dec 04;8:248
pubmed: 19055843
J Innov Health Inform. 2017 Jan 25;23(4):882
pubmed: 28346133
Health Care Manage Rev. 2001 Winter;26(1):56-69; discussion 87-9
pubmed: 11233354

Auteurs

Malte Haring (M)

Hannover Medical School, Institute of Epidemiology, Social Medicine and Health System Research, Carl- Neuberg-Str. 1, 30625, Hannover, Germany. Malte.U.Haring@stud.mh-hannover.de.

Felix Freigang (F)

inav - private institute for applied health services research GmbH, Schiffbauerdamm 12, 10117, Berlin, Germany.

Volker Amelung (V)

Hannover Medical School, Institute of Epidemiology, Social Medicine and Health System Research, Carl- Neuberg-Str. 1, 30625, Hannover, Germany.

Martin Gersch (M)

Department of Information Systems, Freie Universität Berlin, Garystr. 21, 14195, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH